In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Robert Haddad commented on JPMorgan Chase CEO Jamie Dimon being diagnosed with throat cancer.

Tags: HeadNeckCancers

  • Dr. Joyce Liu commented on the Oncologic Drugs Advisory Committee vote to delay approval of the PARP inhibitor olaparib.

Tags: OvarianCancer

  • Johnson & Johnson Innovation Center will fund a $10 million partnership with Dana-Farber and Janssen Biotech to work on lung cancer immunotherapy drugs.

Tags: Immunotherapy

  • Dr. Erica Mayer, a medical oncologist at the Susan F. Smith Center for Women's Cancers at Dana-Farber, explained the concerns over soy consumption and its relationship to breast cancer.

Tags: BreastCancer

  • Dana-Farber is seeking alternative sources for research funding amid a downward trend in the money received from the federal government.

Tags: BasicResearch

  • Dr. Patrick Ott commented on the increased rates of melanoma in older adults.

Tags: Melanoma

  • Dr. Bruce Spiegelman led a study that shows a natural hormone that is increased by physical exercise and by exposure to cold improves blood sugar control, suppresses inflammation, and burns fat.

     

Tags: BasicResearch

  • Dr. J. Dirk Iglehart comments that he now performs about a 10th of the number of mastectomies as when he entered the field in the 1970s.

Tags: BreastCancer, Surgery

  • Erin Harkins, who is being treated at Dana-Farber for Ewing’s sarcoma, attended A Prom to Remember for teens fighting cancer and other life-threatening illnesses.

     

Tags: ChildhoodCancer

  • Dr. Mary-Ellen Taplin commented on a study showing that lung, liver, and other gut metastases are associated with the poorest survival in advanced hormone-refractory prostate cancer.

     

Tags: ProstateCancer

Showing 11-20 of 414 items